Susan ALTSCHULLER

Insider Reports History

Entity
Individual
Location
45 Tennyson St., Somerville, Massachusetts
Signature
/s/ Maiken Keson-Brookes, attorney-in-fact for Susan Altschuller
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Susan ALTSCHULLER:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ImmunoGen, Inc. SVP AND CFO Stock Option (Right to Buy) 124K $564K $4.56 Nov 14, 2022 Direct
Mural Oncology plc Director Ordinary Shares 10K $32.1K $3.21 Aug 14, 2024 Direct
Mural Oncology plc Director Stock Option (right to buy) 8.46K $28.3K $3.35 May 30, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Financial Officer Common Stock 0 $0 $41.18 Aug 1, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Financial Officer Restricted Stock Units 0 $0 $41.18 Aug 1, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Financial Officer Stock Option (Right to Buy) 0 Aug 1, 2024 Direct

Insider Reports Filed by Susan ALTSCHULLER

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MURA Mural Oncology plc Aug 14, 2024 1 $32.1K 4 Aug 15, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Aug 1, 2024 3 $0 4 Aug 5, 2024 Chief Financial Officer
MURA Mural Oncology plc May 30, 2024 1 $0 4/A Jun 5, 2024 Director
MURA Mural Oncology plc May 30, 2024 1 $28.3K 4 Jun 3, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Jan 19, 2024 1 $0 4 Jan 23, 2024 Chief Financial Officer
CERE Cerevel Therapeutics Holdings, Inc. Dec 19, 2023 3 -$572K 4 Dec 21, 2023 Chief Financial Officer
MURA Mural Oncology plc Dec 14, 2023 1 $0 4 Dec 18, 2023 Director
MURA Mural Oncology plc Oct 31, 2023 0 $0 3 Nov 7, 2023 Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 1, 2023 2 $0 4 Jun 5, 2023 Chief Financial Officer
CERE Cerevel Therapeutics Holdings, Inc. May 15, 2023 0 $0 3 May 19, 2023 Chief Financial Officer
IMGN ImmunoGen, Inc. May 20, 2022 2 $0 4 Dec 27, 2022 SVP AND CFO
IMGN ImmunoGen, Inc. Feb 4, 2022 1 $1.92M 4 Feb 8, 2022 SVP & Chief Financial Officer